Xinwen Wang

Dr. Xinwen Wang is an Assistant Professor of Pharmaceutical Sciences and Graduate Faculty II at Northeast Ohio Medical University's College of Graduate Studies. Her research focuses on applying pharmaco-omics tools to identify factors influencing interindividual variability in disease susceptibility and drug responses, particularly in cardiovascular disease, metabolic syndrome, and neurological disorders. She holds a Ph.D. from China Pharmaceutical University and completed postdoctoral training at the University of Michigan.

Education:

• Postdoc in Translational Sciences, University of Michigan (2015-2020)
• Ph.D. in Pharmacokinetics, China Pharmaceutical University (2009-2015)
• B.S. in Pharmacology, China Pharmaceutical University (2005-2009)

Research Interests: Dr. Wang's lab combines proteomics, metabolomics, and genetics to study personalized medicine approaches. Her work bridges basic discovery and clinical application, aiming to optimize therapies through genotype, proteotype, and metabotype-guided precision pharmacotherapy. Key areas include carboxylesterase 1 (CES1) enzyme function, genetic polymorphisms affecting drug metabolism, and metabolic disease mechanisms.

Awards:

• Pre-K Award in Translational Science
• Featured as an emerging talent in Drug Metabolism and Disposition

Grants & Advising: Her NIH-funded projects investigate drug-gene interactions and metabolic pathways. She advises graduate students in pharmacogenomics and proteomics, emphasizing translational outcomes.

Labs & Teams: Leads the Pharmaco-Omics Lab at NEOMED, collaborating with clinical and basic science teams to advance precision medicine strategies.